Global Gene Therapy Technologies, Markets and Companies Report 2016 - Analysis & Forecasts 2015-2025 - Research and Markets

05 Apr, 2016, 08:10 ET from Research and Markets

DUBLIN, April 5, 2016 /PRNewswire/ --

Research and Markets has announced the addition of Jain PharmaBiotech's new report, "Gene Therapy - Technologies, Markets and Companies," to their offering. 

     (Logo: http://photos.prnewswire.com/prnh/20160330/349511LOGO )

Gene therapy technologies are described in detail including viral vectors, nonviral vectors and cell therapy with genetically modified vectors. Gene therapy is an excellent method of drug delivery and various routes of administration as well as targeted gene therapy are described. There is an introduction to technologies for gene suppression as well as molecular diagnostics to detect and monitor gene expression. 

The markets for gene therapy are difficult to estimate as there is only one approved gene therapy product and it is marketed in China since 2004. Gene therapy markets are estimated for the years 2015-2025. The estimates are based on epidemiology of diseases to be treated with gene therapy, the portion of those who will be eligible for these treatments, competing technologies and the technical developments anticipated in the next decades. In spite of some setbacks, the future for gene therapy is bright. The markets for DNA vaccines are calculated separately as only genetically modified vaccines and those using viral vectors are included in the gene therapy markets 

The voluminous literature on gene therapy was reviewed and selected 750 references are appended in the bibliography. The references are constantly updated. The text is supplemented with 75 tables and 18 figures. 

Profiles of 186 companies involved in developing gene therapy are presented along with 229 collaborations. There were only 44 companies involved in this area in 1995. In spite of some failures and mergers, the number of companies has increased more than 4-fold within a decade. These companies have been followed up since they were the topic of a book on gene therapy companies by the author of this report. 

Benefits of this report: 

- Up-to-date one-stop information on gene therapy with 75 tables and 17 figures 
- Evaluation of gene therapy technologies 
- 750 selected references from the literature 
- Estimates of gene therapy markets from 2015-2025 
- Profiles of 186 companies involved and collaborations in this area 

Key Topics Covered: 

Part I: Technologies & Markets 

Executive Summary 

1. Introduction

2. Gene Therapy Technologies

3. Clinical Applications of Gene Therapy

4. Gene Therapy of Genetic Disorders

5. Gene Therapy of Cancer

6. Gene Therapy of Neurological Disorders

7. Gene Therapy of Cardiovascular Disorders

8. Gene therapy of viral infections

9. Research, Development and Future of Gene Therapy

10. Regulatory, Safety and Ethical Issues of Gene Therapy

11. Markets for Gene Therapy

12. References 

Part II: Companies 

13. Companies involved in Gene Therapy 

For more information visit http://www.researchandmarkets.com/research/fhfkkz/gene_therapy 

Source: Jain PharmaBiotech

Media Contact: 

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets